Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Completed 3Withdrawn 2Unknown 2Terminated 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Neuroma, Acoustic 2

Interventions

Cyclophosphamide 129Cisplatin 119Radiotherapy 115pembrolizumab 111Carboplatin 97Paclitaxel 96Gemcitabine 96Magnetic Resonance Spectroscopy 80Nivolumab 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Biopsy 53Doxorubicin 52fludarabine 51Drug Therapy 45durvalumab 44Cytarabine 44Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Surveys and Questionnaires 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Gentamicins × Clear all
NCT02379754 2020-09-11

Gentamicin Treatment Prior to Schwannoma Surgery - Residual Function

Lund University

Phase 4 Withdrawn
CNS

Neuroma, Acoustic

NCT02415257 2020-09-11

Gentamicin Treatment Prior to Schwannoma Surgery - No Residual Function

Lund University

Phase 4 Withdrawn
CNS

Neuroma, Acoustic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡